GoodRx (NASDAQ:GDRX) Trading Up 6.6% - Should You Buy?

GoodRx Holdings, Inc. (NASDAQ:GDRX - Get Free Report) shares rose 6.6% during mid-day trading on Thursday . The stock traded as high as $5.43 and last traded at $5.21. Approximately 406,469 shares changed hands during trading, a decline of 65% from the average daily volume of 1,148,701 shares. The stock had previously closed at $4.89.

Analyst Upgrades and Downgrades

GDRX has been the subject of several recent analyst reports. Citigroup dropped their price target on GoodRx from $7.00 to $6.25 and set a "buy" rating for the company in a research note on Friday, January 10th. Wells Fargo & Company cut their target price on shares of GoodRx from $9.00 to $8.00 and set an "overweight" rating for the company in a research note on Friday. KeyCorp decreased their price target on shares of GoodRx from $7.00 to $6.00 and set an "overweight" rating on the stock in a research note on Wednesday, January 8th. Morgan Stanley cut their price objective on GoodRx from $7.00 to $6.00 and set an "equal weight" rating for the company in a research report on Tuesday, December 17th. Finally, Mizuho started coverage on GoodRx in a research report on Wednesday, December 4th. They issued a "neutral" rating and a $5.00 target price on the stock. Three analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, GoodRx has an average rating of "Moderate Buy" and an average price target of $8.18.

GoodRx Stock Performance

The firm has a market capitalization of $1.85 billion, a PE ratio of -161.67, a P/E/G ratio of 2.46 and a beta of 1.28. The business has a 50-day simple moving average of $4.71 and a 200-day simple moving average of $5.71. The company has a debt-to-equity ratio of 0.70, a current ratio of 5.48 and a quick ratio of 5.48.

Remove Ads

Institutional Trading of GoodRx

A number of institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. raised its stake in shares of GoodRx by 5.8% in the fourth quarter. Vanguard Group Inc. now owns 8,373,039 shares of the company's stock valued at $38,935,000 after acquiring an additional 460,753 shares during the period. Rubric Capital Management LP raised its position in GoodRx by 25.2% in the 3rd quarter. Rubric Capital Management LP now owns 4,680,028 shares of the company's stock worth $32,479,000 after purchasing an additional 943,226 shares during the period. Dimensional Fund Advisors LP lifted its stake in GoodRx by 22.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,992,311 shares of the company's stock worth $9,264,000 after purchasing an additional 369,553 shares during the last quarter. Point72 Asset Management L.P. purchased a new position in shares of GoodRx during the third quarter valued at approximately $11,295,000. Finally, Clearbridge Investments LLC bought a new position in shares of GoodRx during the fourth quarter valued at approximately $5,863,000. 63.77% of the stock is currently owned by institutional investors.

About GoodRx

GoodRx Holdings, Inc, together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices.